Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Destée

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|January 20, 2009
A new perspective on brain derived neurotrophin factor polymorphism in L-dopa induced dyskinesiaCaroline Moreau, Alain Destée
The New England Journal of Medicine|February 28, 2009
Levodopa for Parkinson's diseaseDavid Devos, Caroline Moreau, Alain Destée
European Neurology|November 29, 2008
Is there a difference between levodopa/ dopa-decarboxylase inhibitor and entacapone and levodopa/dopa-decarboxylase inhibitor dose fractionation strategies in Parkinson's disease patients experiencing symptom re-emergence due to wearing-off? The Honeymoon StudyAlain Destée, Karin Rérat, Isabelle Bourdeix
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 2008
The Lille Apathy Rating Scale: validation of a caregiver-based versionKathy Dujardin, Pascal Sockeel, Marie Delliaux, et al.
Journal of Neurology|December 14, 2004
Orofacial apraxia in corticobasal degeneration, progressive supranuclear palsy, multiple system atrophy and Parkinson's diseaseCanan Ozsancak, Pascal Auzou, Kathy Dujardin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 13, 2009
Apathy may herald cognitive decline and dementia in Parkinson's diseaseKathy Dujardin, Pascal Sockeel, Marie Delliaux, et al.
Neuroscience Letters|July 19, 2002
Mutation analysis and association studies of the ubiquitin carboxy-terminal hydrolase L1 gene in Huntington's diseasePeggy Nazé, Isabelle Vuillaume, Alain Destée, et al.
Journal of Neurology|May 28, 2004
Comparison of secondary vascular prevention in practice after cerebral ischemia and coronary heart diseaseMarie Girot, Dominique Deplanque, Florence Pasquier, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|March 3, 2005
Ictal movement disorders and hypothalamic hamartomaWilliam Szurhaj, Christine Daems-Monpeurt, Haouaria Sediri, et al.
Behavioural Pharmacology|May 5, 2010
Differing short-term neuroprotective effects of the fibrates fenofibrate and bezafibrate in MPTP and 6-OHDA experimental models of Parkinson's diseaseAlexandre Kreisler, Alain Duhamel, Christel Vanbesien-Mailliot, et al.
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Journal of Neurology, Neurosurgery, and Psychiatry|January 20, 2009
A new perspective on brain derived neurotrophin factor polymorphism in L-dopa induced dyskinesiaCaroline Moreau, Alain Destée
The New England Journal of Medicine|February 28, 2009
Levodopa for Parkinson's diseaseDavid Devos, Caroline Moreau, Alain Destée
European Neurology|November 29, 2008
Is there a difference between levodopa/ dopa-decarboxylase inhibitor and entacapone and levodopa/dopa-decarboxylase inhibitor dose fractionation strategies in Parkinson's disease patients experiencing symptom re-emergence due to wearing-off? The Honeymoon StudyAlain Destée, Karin Rérat, Isabelle Bourdeix
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 2008
The Lille Apathy Rating Scale: validation of a caregiver-based versionKathy Dujardin, Pascal Sockeel, Marie Delliaux, et al.
Journal of Neurology|December 14, 2004
Orofacial apraxia in corticobasal degeneration, progressive supranuclear palsy, multiple system atrophy and Parkinson's diseaseCanan Ozsancak, Pascal Auzou, Kathy Dujardin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 13, 2009
Apathy may herald cognitive decline and dementia in Parkinson's diseaseKathy Dujardin, Pascal Sockeel, Marie Delliaux, et al.
Neuroscience Letters|July 19, 2002
Mutation analysis and association studies of the ubiquitin carboxy-terminal hydrolase L1 gene in Huntington's diseasePeggy Nazé, Isabelle Vuillaume, Alain Destée, et al.
Journal of Neurology|May 28, 2004
Comparison of secondary vascular prevention in practice after cerebral ischemia and coronary heart diseaseMarie Girot, Dominique Deplanque, Florence Pasquier, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|March 3, 2005
Ictal movement disorders and hypothalamic hamartomaWilliam Szurhaj, Christine Daems-Monpeurt, Haouaria Sediri, et al.
Behavioural Pharmacology|May 5, 2010
Differing short-term neuroprotective effects of the fibrates fenofibrate and bezafibrate in MPTP and 6-OHDA experimental models of Parkinson's diseaseAlexandre Kreisler, Alain Duhamel, Christel Vanbesien-Mailliot, et al.
Pageof 10